ArticleCurrent oncology (Toronto, Ont.)2026

Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve

Atsuko Hirabae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.